American Marconi Wireless News

NYSE - LSE

RBGPF	-19.57%	69	$
CMSD	-1.07%	22.658	$
BCC	-2.28%	68.3	$
GSK	-1.02%	51.84	$
NGG	-4.32%	81.99	$
BCE	0.23%	25.79	$
CMSC	-0.88%	22.65	$
RELX	-1.38%	33.36	$
BP	-2.41%	44.78	$
RYCEF	-8.21%	15.34	$
BTI	-2.35%	57.37	$
RIO	-3.01%	83.15	$
AZN	-2.9%	183.6	$
JRI	-3.31%	11.77	$
VOD	-0.63%	14.33	$

Featured

Syrians protest alcohol sale limits, curbs on personal freedom

Hundreds of Syrians protested in central Damascus on Sunday against new restrictions on alcohol sales, reflecting wider fears that the Islamist authorities may tighten curbs on personal freedoms.

Torrential rains in Kenya kill 81 in March: officials

Torrential storms that have triggered flash floods in Kenya have killed at least 81 people this month, authorities said Sunday, as rain continued to pound much of the country.

Last news

Treating Measles Infection: Nanoviricides CEO Dr Anil Diwan Interviewed by Steve Darling from Proactive

SHELTON, CONNECTICUT / ACCESS Newswire / October 29, 2025 / NanoViricides, Inc., a publicly traded company (NYSE Amer.:NNVC) (the "Company"), announced that Nanoviricides CEO Dr Anil Diwan joined Steve Darling from Proactive to share major progress in the company's antiviral research in a video interview. The interview can be viewed at https://youtu.be/m_3Yk4_832E .

New Release Shines Light on a Shocking True Story of Justice Denied

USA v Raj by Dr. Raj Bothra and Jenifer DeBellis Released September 11, 2025

New Generation Consumer Group's Signature Apps in Talks to Acquire Revenue-Generating Subscription App Companies

PHOENIX, AZ / ACCESS Newswire / October 29, 2025 / New Generation Consumer Group (OTCID:NGCG) announced today that its subsidiary, Signature Apps, is in active discussions to acquire multiple revenue-generating app and service companies. The target companies operate on subscription-based models, delivering consistent, recurring revenues that align with Signature Apps' strategy to scale its digital product suite and expand its customer base.

Medicus Pharma Ltd. Announces Collaboration with the Gorlin Syndrome Alliance to Pursue Compassionate Use Pathway for Skinject(TM) in Patients with Gorlin Syndrome

Gorlin Syndrome, also known as Nevoid Basal Cell Carcinoma Syndrome, is a rare inherited genetic disorder affecting 1 in 31,000 people worldwide that can develop 500-1000 Basal Cell Carcinoma (BCC) lesions over lifetime

Specificity Signs LOI with Blackpearl Group to Build the World's Only Fully Integrated Ad Tech Stack, Launching a Direct Attack on Big Tech Fraud

TAMPA, FLORIDA / ACCESS Newswire / October 29, 2025 / Specificity (OTCID:SPTY), the leader in precision digital marketing, today announced it has signed a Letter of Intent (LOI) with New Zealand-based Blackpearl Group (BPG) to build and host a proprietary Private Data Platform- creating what companies describe as the world's only fully integrated ad tech stack. This move cements Specificity's path to major market disruption and positions the company to tackle the estimated $250 billion fraud problem plaguing the digital advertising industry, driven largely by bot and mechanical traffic.

Lex LasVegas to Emcee Compassion Center's Coalition for Patient Rights Inaugural Hoedown, Nov. 15 at Paradise Recreation Center

The Compassion Center and its Coalition for Patient Rights (CPR) tap Las Vegas mainstay Lex LasVegas to host a family-friendly day of music, advocacy, and community well-being on Saturday, November 15, 2025, 10 a.m.-6 p.m., at 4775 McLeod Dr., Las Vegas, NV 89121. In the lead-up, fans are invited to The Official 4Horsemen of Comedy Costume Party & Legendary 4Horseman Khalil Mack's Birthday on Wednesday, October 29, 2025, 9 p.m.-1 a.m.++ at Hola Habibi, with Blaque Tacos and a prize for Best Outfit.

Evotec SE to Announce Results for The First Nine Months 2025 on 05 November 2025

HAMBURG, DE / ACCESS Newswire / October 29, 2025 / Evotec SE (Frankfurt Stock Exchange: EVT, SDAX/TecDAX, Prime Standard, ISIN: DE0005664809, WKN 566480; NASDAQ:EVO) will announce its interim statement for the first nine months 2025 on Wednesday, 05 November 2025.

Hemogenyx Pharmaceuticals PLC Announces Clinical Trial Update and Grant of Share Awards

DSMB Clearance to Proceed to the Next Dose Level of HG-CT-1 in Adult Patients, Opening Pediatric Recruitment, and Grant of Restricted Share Units to Hemogenyx Team

Relief Therapeutics Announces Positive Results from Pivotal Bioequivalence Study of RLF-OD032

RLF-OD032 demonstrated bioequivalence to KUVAN® PowderStudy results support planned 505(b)(2) NDA submission in early 2026

'Catastrophic' hurricane slams Jamaica with fierce winds and rain

Hurricane Melissa ripped up trees and knocked out power after making landfall in Jamaica on Tuesday as one of the most powerful hurricanes on record, inundating the island nation with rains that threaten flash floods and landslides.

At least 64 killed in war-like Rio drug raids

Bodies piled up in poor neighborhoods of Rio de Janeiro on Tuesday as police launched their biggest ever raids on the city's drug traffickers, leaving at least 64 dead in war-like scenes.

At least 64 killed in Rio drug raid

Hundreds of heavily armed Brazilian police raided slum areas of Rio in a drug raid Tuesday, touching off firefights likened to scenes from a war and leaving at least 64 people dead, Brazilian officials said.

French prosecutors seek suspended jail terms in Brigitte Macron cyberbullying case

French prosecutors on Tuesday sought suspended prison terms of three to 12 months for defendants accused of cyberbullying First Lady Brigitte Macron by spreading unsubstantiated claims about her gender.

At least 18 suspects killed in Rio anti-drug raid: governor

At least 18 suspects and some police officers were killed Tuesday during a massive anti-drug raid in Rio de Janeiro, Brazilian authorities said, as prolonged gun battles erupted and demolition vehicles destroyed street barricades.

Giant Hurricane Melissa hours from bullseye hit on Jamaica

Hurricane Melissa was only hours away Tuesday from expected landfall on Jamaica, bringing devastating flooding and winds that officials warn will smash the small Caribbean nation's infrastructure.

The Voice of the Martyrs Releases Daniel and Aline: Democratic Republic of the Congo, a Short Film for 2025 International Day of Prayer for Persecuted Christians

BARTLESVILLE, OK / ACCESS Newswire / October 28, 2025 / The Voice of the Martyrs (VOM) has released a new short feature film telling the powerful story of Daniel and Aline, two courageous Congolese Christians bringing hope and healing to fellow believers traumatized by kidnapping, violence and loss in the Democratic Republic of the Congo (DRC).

Desert Oasis Healthcare Expands Maternal Health Resources with New Maternal Health Educator Position and Updated Video Education Series

DOHC strengthens its commitment to mothers and families through expanded education and personalized prenatal support

Newsmax to Report Third Quarter 2025 Financial Results

BOCA RATON, FL / ACCESS Newswire / October 28, 2025 / Newsmax Inc. (NYSE:NMAX) ("Newsmax" or the "Company") today announced that the Company will report financial results for the third quarter ended September 30, 2025 on Thursday, November 13, 2025, after the U.S. stock market closes.

Sunshine Biopharma Scores a Major Regulatory Win to Market Domperidone in Canada (NASDAQ: SBFM)

FORT LAUDERDALE, FL / ACCESS Newswire / October 28, 2025 / Momentum has a way of separating the contenders from the crowd. Sunshine Biopharma (NASDAQ:SBFM) is quickly establishing which side of that line it's on. After scoring another major regulatory win, that position certainly isn't one of many in the crowd. On Tuesday, the company announced that it had secured Health Canada authorization to commercialize domperidone through its Nora Pharma subsidiary, a milestone that not only expands its commercial reach but also validates its growing track record of revenue-generating execution.

Who is Javad Sajan?

Javad Sajan is the best plastic surgeon in Seattle.

Vanderbilt Report NextTrip CEO Interview: NextTrip Builds What Traditional Travel Companies Couldn't

BRISTOL, TN / ACCESS Newswire / October 28, 2025 / Most online travel agencies can't prove their advertising works.

Exousia Pro is Excited to Announce that it has Received Orphan Drug Designation from the FDA

Exousia Pro is in a unique position, as only 11% of ODAs are awarded at the preclinical stage.

Medical Care Technologies Inc. (OTC PINK:MDCE) Nears Completion of AI-Powered App Targeting the $4.5 Billion Global Nutrition & Recipe Market

MESA, ARIZONA / ACCESS Newswire / October 28, 2025 / Medical Care Technologies Inc. (OTC PINK:MDCE) announced today that its first AI-driven mobile application, [App Name Pending Trademark], has entered its final development phase. The app uses image recognition to create recipes and also analyzes nutrition data directly from food photos. MDCE plans to deploy the app in 175 countries and in over 30 languages.

Dolphin (NASDAQ:DLPN) Named One of Crain's Best Places to Work in NYC 2025

NEW YORK, NY / ACCESS Newswire / October 28, 2025 / Dolphin (NASDAQ:DLPN) is proud to announce it has been recognized by Crain's New York Business as one of the Best Places to Work in New York City for 2025. The annual ranking honors companies that go above and beyond in creating workplaces defined by collegiality, collaboration, and care. Employers are evaluated on leadership, culture, professional development, benefits, and employee satisfaction.

Aytu BioPharma Announces Patent Term Extension for EXXUA(TM)

DENVER, CO / ACCESS Newswire / October 28, 2025 / Aytu BioPharma, Inc. (the "Company" or "Aytu") (Nasdaq:AYTU), a pharmaceutical company focused on advancing innovative medicines for complex central nervous system diseases to improve the quality of life for patients, today announced that the method of use patent (U.S. Patent No. 7,538,116) for EXXUATM (gepirone) extended-release tablets ("EXXUA") has been extended through September 2, 2030 under 35 U.S.C. 156. The patent extension further expands upon the new chemical entity ("NCE") exclusivity period granted by the United States Food and Drug Administration ("FDA"). Gepirone is an NCE, and EXXUA is the first-in-class selective serotonin 5HT1a receptor agonist approved by the FDA for the treatment of major depressive disorder ("MDD") in adults.

The NITE FLAG XL Launches October 28, 2025 - The Flag of the 21st Century

THE FUTURE OF FLAGS IS NOW- THE NITE FLAG COMPANY"Always Waves. Never Sags. Lights Up the Night."

Modular Medical Announces Ongoing Progress to Obtain CE Mark

Key Highlights:Pivot continues to progress toward CE Mark certification in 2026Stage 1 ISO Audit completed with Stage 2 planned for 1H2026

VSee Awarded US Department of Health & Human Services FedRAMP High ATO

SAN JOSE, CALIFORNIA / ACCESS Newswire / October 28, 2025 / VSee Health, Inc. (Nasdaq:VSEE) (the "Company"), announced it has received its Authority to Operate (ATO) at the FedRAMP High level from the U.S. Department of Health and Human Services (HHS). The authorization also allows other federal agencies to use VSee where FedRAMP High is required.

Florence Healthcare Launches SiteLink on AWS Marketplace, Extending its Clinical Trial Operations Platform Capabilities to Cloud

ATLANTA, GEORGIA / ACCESS Newswire / October 28, 2025 / Florence Healthcare, the leading clinical trial platform connecting pharmaceutical sponsors and research sites worldwide, announced today that SiteLink, a key offering of Florence's Trial Operations Platform, is now available in AWS Marketplace.

Sunshine Biopharma Gains FDA-Equivalent Clearance in Canada for Domperidone to Treat Cancer-related Nausea

FORT LAUDERDALE, FL / ACCESS Newswire / October 28, 2025 / Sunshine Biopharma Inc. (NASDAQ:SBFM) (the "Company"), a leading pharmaceutical company focused on innovative and affordable healthcare solutions, today announced that its wholly owned subsidiary, Nora Pharma Inc., has received approval from Health Canada, the Canadian equivalent to the FDA, for the commercialization of Domperidone, a prescription medication used to relieve nausea and vomiting and to enhance gastrointestinal motility.

Date Change for Bike MS: Historic New Bern Ride 2026!

Cycling for a Cure to End Multiple Sclerosis

CBD Life Sciences Inc. (OTC: CBDL) Launches Tremendous Energy & Weight-Loss Diet Hemp-Free Gummies

Global functional gummy supplements market projected to surpass $50 billion by 2030 - CBDL expands into two of the fastest-growing segments in wellness and performance nutrition.

American Marconi Wireless News - Boulevard (English)